"I hope you make a lot of money here boi, and there is a good chance you will even with the waste of years due to blunders."
-------------------------------------------------------------------------------
The so called "wasted years" has allowed me and the 9 people I advise to accumulate large sums of shares cheaply since Rett, more than double.
This year our group has 'almost' topped off in shares and have switched strategies; and we are accumulating call options, specifically the Jan 15, 2027 calls, mostly in the $20 range.
By by Jan 15, 2027 we see it as highly likely that EMA and FDA approvals will have already happened. A $20 call should be worth many, many multiples of $20 (plus minor costs). These Jan 15th 2027 call options will have EMA and FDA approvals already behind them, and will soar in value, yet at little cost in todays 2027 option prices.
..."In the USA, over 7 million people currently have Alzheimer's disease (AD), with approximately 7.2 million Americans age 65 and older living with it in 2025. In Europe, about 7 million people are estimated to live with Alzheimer's disease, a number projected to increase to 14 million by 2030."
That is going to bring mind boggling revenue to Anavex with EMA and FDA approvals well before Jan 15, 2027.
BTW Hoskuld this is not a knock on you, I'm just presenting a different perspective. I think your knowledge brings opinions that are always worth consideration, GLTY.
I'm sure Boi and other longs posting here have taken advantage of the low prices during that "wasted" period and used the extended time to accumulate shares, and for some the Jan 15, 2027 call options too. Personally I do not call that period of time a "waste", to our group it was opportunity to significantly expand our holdings in shares, and now the Jan 2027 call options we will continue to accumulate.
Market Data 
Markets 
